Martin B Draznin, MD
Professor Emeritus, Department of Pediatric and Adolescent Medicine
Biosketch
-
Board Certification
- American Board of Pediatrics (General Pediatrics)
- American Board of Pediatrics (Pediatric Endocrinology)
-
Education and Training
- Research Fellowship 1983, Clinical Pharmacology, Veterans Administration Medical Center, Stanford University Medical School, Stanford University
- Fellowship 1981, Clinical Pharmacology, University of Virginia Hospital, University of Virginia
- Fellowship 1981, Pediatric Endocrinology, University of Virginia Hospital, University of Virginia
- Residency 1977, Pediatrics, Michael Reese Hospital Medical Center,
- Residency 1976, Pediatrics, Children's Memorial Hospital,
- MD 1974, Northwestern University
- AB 1970, Biology (Cum Laude), Harvard University
-
Publications
Draznin M., Borgohain P., Kanungo S. Newborn Screening in Pediatric Endocrine Disorders Endocrines. 2022;3:107-114.
Draznin M.B., Kanungo S. Special Issue “Genetics in Pediatric Endocrinology” Endocrines. 2022;3:601-602.
Richards G.E., Thomsett M.J., Boston B.A., Dimeglio L.A., Shulman D.I., Draznin M. Natural history of idiopathic diabetes insipidus Journal of Pediatrics. 2011;159(4):566-570.
Skakkebaek N.E., Toppari J., Söder O., Gordon C.M., Divall S., Draznin M. The exposure of fetuses and children to endocrine disrupting chemicals: A European Society for Paediatric Endocrinology (ESPE) and Pediatric Endocrine Society (PES) call to action statement Journal of Clinical Endocrinology and Metabolism. 2011;96(10):3056-3058.
Draznin M.B. Managing the Adolescent Athlete with Type 1 Diabetes Mellitus Pediatric Clinics of North America. 2010;57(3):829-837.
Draznin M.B. Type 2 diabetes Adolescent Medicine: State of the Art Reviews. 2008;19(3):498-506.
Kamboj M.K., Draznin M.B. Office Management of the Adolescent with Diabetes Mellitus Primary Care - Clinics in Office Practice. 2006;33(2):581-602.
Bricker L.A., Draznin M.B., Hare J.D., Greydanus D.E. Diabetes in adolescent patients : Diagnostic dilemmas Indian Journal of Pediatrics. 2001;68:223-227.
Draznin M.B. Type 1 diabetes and sports participation: Strategies for training and competing safely Physician and Sportsmedicine. 2000;28(12):49-56.
Draznin M.B., Patel D.R. Diabetes mellitus and sports. Adolescent medicine (Philadelphia, Pa.). 1998;9
Foley T.P., Abbassi V., Copeland K., Draznin M.B. Hypothyroidism caused by chronic autoimmune thyroiditis in very young infants New England Journal of Medicine. 1994;330(7):466-468.
Owerbach D., Ballard A.L., Draznin M.B. Salt-wasting congenital adrenal hyperplasia: Detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction Journal of Clinical Endocrinology and Metabolism. 1992;74(3):553-558.
Owerbach D., Draznin M., Carpenter R., Greenberg F. Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia using the polymerase chain reaction Human Genetics. 1992;89(1):109-110.
Samaan N.A., Draznin M.B., Halpin R.E., Bloss R., Hawkins E., Lewis R.A. Multiple endocrine syndrome type IIb in early childhood Cancer. 1991;68(8):1832-1834.
Owerbach D., Crawford Y.M., Draznin M.B. Direct analysis of CYP21B genes in 21-hydroxylase deficiency using polymerase chain reaction amplification Molecular Endocrinology. 1990;4(1):125-131.
Draznin M., Rapoport R.M., Murad F. Myosin light chain phosphorylation in contraction and relaxation of intact rat thoracic aorta International Journal of Biochemistry. 1986;18(10):917-928.
Rapoport R.M., Draznin M.B., Murad F. Mechanisms of adenosine triphosphate-, thrombin-, and trypsin-induced relaxation of rat thoracic aorta Circulation Research. 1984;55(4):468-479.
Murad F. Effects of norepinephrine, sodium nitroprusside, calcium-free buffer and a calmodulin inhibitor on protein phosphorylation related to contraction and relaxation in intact rat aorta Clinical Research. 1983;31(1)
Rapoport R.M., Draznin M.B., Martinez G.A., Murad F. Effect of endothelium-dependent vasodilators on relaxation, cyclic GMP levels and protein phosphorylation in rat thoracic aorta Clinical Research. 1983;31(1)
Rapoport R.M., Draznin M.B., Murad F. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation Nature. 1983;306(5939):174-176.
Rapoport R.M., Draznin M.B., Murad F. Endothelium-dependent vasodilator-and nitrovasodilator-induced relaxation may be mediated through cyclic GMP formation and cyclic GMP-dependent protein phosphorylation. Transactions of the Association of American Physicians. 1983;96:19-30.
Jane J., Rudolf L.E., Horvath E., Kovacs K., Vale W. Somatotroph hyperplasia: successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. Transactions of the Association of American Physicians. 1982;95:177-187.
Rapoport R.M., Draznin M.B., Murad F. Sodium nitroprusside-induced protein phosphorylation in intact rat aorta is mimicked by 8-bromo cyclic GMP Proceedings of the National Academy of Sciences of the United States of America. 1982;79(21 I):6470-6474.
Rapoport R.M., Draznin M.B., Murad F. Sodium nitroprusside-induced protein phosphorylation in intact rat aorta is mimicked by 8-bromo-cyclic GMP Clinical Research. 1982;30(2)
Thorner M.O., Perryman R.L., Cronin M.J., Rogol A.D., Draznin M., Johanson A., Vale W., Horvath E., Kovacs K. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor Journal of Clinical Investigation. 1982;70(5):965-977.
Rapaport R., Levine L.S., Petrovic M., Wilson T., Draznin M., Bejar R.L., Johanson A., New M.I. The renin-aldosterone system in cystic fibrosis Journal of Pediatrics. 1981;98(5):768-771.
Draznin M., Stelling M.W., Johanson A.J. Silver-Russell syndrome and craniopharyngioma The Journal of Pediatrics. 1980;96(5):887-889.
Draznin M., Esterly N.B., Fretzin D.F. Congenital Poikiloderma With Features of Hereditary Acrokeratotic Poikiloderma Archives of Dermatology. 1978;114(8):1207-1210.